Advertisement
Review Article| Volume 38, ISSUE 1, P125-139, February 2012

Vitamin D and the Immune System: New Perspectives on an Old Theme

Published:April 16, 2012DOI:https://doi.org/10.1016/j.rdc.2012.03.012

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Rheumatic Disease Clinics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Eisman J.A.
        • Martin T.J.
        • MacIntyre I.
        • et al.
        1,25-Dihydroxyvitamin-D-receptor in breast cancer cells.
        Lancet. 1979; 2: 1335
        • Manolagas S.C.
        • Haussler M.R.
        • Deftos L.J.
        1,25-Dihydroxyvitamin D3 receptors in cancer.
        Lancet. 1980; 1: 828
        • Abe E.
        • Miyaura C.
        • Sakagami H.
        • et al.
        Differentiation of mouse myeloid leukemia cells induced by 1alpha,25-dihydroxyvitamin D3.
        Proc Natl Acad Sci U S A. 1981; 78: 4990
        • Colston K.
        • Colston M.J.
        • Feldman D.
        1,25-Dihydroxyvitamin D3 and malignant melanoma: the presence of receptors and inhibition of cell growth in culture.
        Endocrinology. 1981; 108: 1083
        • Abe E.
        • Miyaura C.
        • Tanaka H.
        • et al.
        1 alpha,25-dihydroxyvitamin D3 promotes fusion of mouse alveolar macrophages both by a direct mechanism and by a spleen cell-mediated indirect mechanism.
        Proc Natl Acad Sci U S A. 1983; 80: 5583
        • Bhalla A.K.
        • Amento E.P.
        • Serog B.
        • et al.
        1,25-Dihydroxyvitamin D3 inhibits antigen-induced T cell activation.
        J Immunol. 1984; 133: 1748
        • Bell N.H.
        • Stern P.H.
        • Pantzer E.
        • et al.
        Evidence that increased circulating 1alpha, 25-dihydroxyvitamin D is the probable cause for abnormal calcium metabolism in sarcoidosis.
        J Clin Invest. 1979; 64: 218
        • Papapoulos S.E.
        • Clemens T.L.
        • Fraher L.J.
        • et al.
        1,25-Dihydroxycholecalciferol in the pathogenesis of the hypercalcaemia of sarcoidosis.
        Lancet. 1979; 1: 627
        • Adams J.S.
        • Gacad M.A.
        Characterization of 1 alpha-hydroxylation of vitamin D3 sterols by cultured alveolar macrophages from patients with sarcoidosis.
        J Exp Med. 1985; 161: 755
        • Adams J.S.
        • Sharma O.P.
        • Gacad M.A.
        • et al.
        Metabolism of 25-hydroxyvitamin D3 by cultured pulmonary alveolar macrophages in sarcoidosis.
        J Clin Invest. 1983; 72: 1856
        • Barbour G.L.
        • Coburn J.W.
        • Slatopolsky E.
        • et al.
        Hypercalcemia in an anephric patient with sarcoidosis: evidence for extrarenal generation of 1,25-dihydroxyvitamin D.
        N Engl J Med. 1981; 305: 440
        • Hewison M.
        Vitamin D and the immune system.
        J Endocrinol. 1992; 132: 173
        • Hewison M.
        • Burke F.
        • Evans K.N.
        • et al.
        Extra-renal 25-hydroxyvitamin D3-1alpha-hydroxylase in human health and disease.
        J Steroid Biochem Mol Biol. 2007; 103: 316
        • Griffin M.D.
        • Xing N.
        • Kumar R.
        Vitamin D and its analogs as regulators of immune activation and antigen presentation.
        Annu Rev Nutr. 2003; 23: 117
        • Van Etten E.
        • Decallonne B.
        • Verlinden L.
        • et al.
        Analogs of 1alpha,25-dihydroxyvitamin D3 as pluripotent immunomodulators.
        J Cell Biochem. 2003; 88: 223
        • Koeffler H.P.
        • Amatruda T.
        • Ikekawa N.
        • et al.
        Induction of macrophage differentiation of human normal and leukemic myeloid stem cells by 1,25-dihydroxyvitamin D3 and its fluorinated analogues.
        Cancer Res. 1984; 44: 5624
        • Tanaka H.
        • Abe E.
        • Miyaura C.
        • et al.
        1 alpha,25-Dihydroxyvitamin D3 induces differentiation of human promyelocytic leukemia cells (HL-60) into monocyte-macrophages, but not into granulocytes.
        Biochem Biophys Res Commun. 1983; 117: 86
        • Kreutz M.
        • Andreesen R.
        • Krause S.W.
        • et al.
        1,25-Sihydroxyvitamin D3 production and vitamin D3 receptor expression are developmentally regulated during differentiation of human monocytes into macrophages.
        Blood. 1993; 82: 1300
        • Koeffler H.P.
        • Reichel H.
        • Bishop J.E.
        • et al.
        Gamma-interferon stimulates production of 1,25-dihydroxyvitamin D3 by normal human macrophages.
        Biochem Biophys Res Commun. 1985; 127: 596
        • Liu P.T.
        • Stenger S.
        • Li H.
        • et al.
        Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response.
        Science. 2006; 311: 1770
        • Adams J.S.
        • Ren S.
        • Liu P.T.
        • et al.
        Vitamin D-directed rheostatic regulation of monocyte antibacterial responses.
        J Immunol. 2009; 182: 4289
        • Gombart A.F.
        • Borregaard N.
        • Koeffler H.P.
        Human cathelicidin antimicrobial peptide (CAMP) gene is a direct target of the vitamin D receptor and is strongly up-regulated in myeloid cells by 1,25-dihydroxyvitamin D3.
        FASEB J. 2005; 19: 1067
        • Wang T.T.
        • Nestel F.P.
        • Bourdeau V.
        • et al.
        Cutting edge: 1,25-dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression.
        J Immunol. 2004; 173: 2909
        • Stoffels K.
        • Overbergh L.
        • Giulietti A.
        • et al.
        Immune regulation of 25-hydroxyvitamin-d(3)-1alpha-hydroxylase in human monocytes.
        J Bone Miner Res. 2006; 21: 37
        • Krutzik S.R.
        • Hewison M.
        • Liu P.T.
        • et al.
        IL-15 links TLR2/1-induced macrophage differentiation to the vitamin D-dependent antimicrobial pathway.
        J Immunol. 2008; 181: 7115
        • Peric M.
        • Koglin S.
        • Kim S.M.
        • et al.
        IL-17A enhances vitamin D3-induced expression of cathelicidin antimicrobial peptide in human keratinocytes.
        J Immunol. 2008; 181: 8504
        • Ren S.
        • Nguyen L.
        • Wu S.
        • et al.
        Alternative splicing of vitamin D-24-hydroxylase: a novel mechanism for the regulation of extrarenal 1,25-dihydroxyvitamin D synthesis.
        J Biol Chem. 2005; 280: 20604
        • Schauber J.
        • Dorschner R.A.
        • Coda A.B.
        • et al.
        Injury enhances TLR2 function and antimicrobial peptide expression through a vitamin D-dependent mechanism.
        J Clin Invest. 2007; 117: 803
        • Schauber J.
        • Dorschner R.A.
        • Yamasaki K.
        • et al.
        Control of the innate epithelial antimicrobial response is cell-type specific and dependent on relevant microenvironmental stimuli.
        Immunology. 2006; 118: 509
        • Yim S.
        • Dhawan P.
        • Ragunath C.
        • et al.
        Induction of cathelicidin in normal and CF bronchial epithelial cells by 1,25-dihydroxyvitamin D(3).
        J Cyst Fibros. 2007; 6: 403
        • Liu N.
        • Kaplan A.T.
        • Low J.
        • et al.
        Vitamin D induces innate antibacterial responses in human trophoblasts via an intracrine pathway.
        Biol Reprod. 2009; 80: 398
        • Evans K.N.
        • Bulmer J.N.
        • Kilby M.D.
        • et al.
        Vitamin D and placental-decidual function.
        J Soc Gynecol Investig. 2004; 11: 263
        • Makishima M.
        • Lu T.T.
        • Xie W.
        • et al.
        Vitamin D receptor as an intestinal bile acid sensor.
        Science. 2002; 296: 1313
        • D'Aldebert E.
        • Biyeyeme Bi Mve M.J.
        • Mergey M.
        • et al.
        Bile salts control the antimicrobial peptide cathelicidin through nuclear receptors in the human biliary epithelium.
        Gastroenterology. 2009; 136: 1435
        • Matsunawa M.
        • Amano Y.
        • Endo K.
        • et al.
        The aryl hydrocarbon receptor activator benzo[a]pyrene enhances vitamin D3 catabolism in macrophages.
        Toxicol Sci. 2009; 109: 50-58
        • Sadeghi K.
        • Wessner B.
        • Laggner U.
        • et al.
        Vitamin D3 down-regulates monocyte TLR expression and triggers hyporesponsiveness to pathogen-associated molecular patterns.
        Eur J Immunol. 2006; 36: 361
        • Brennan A.
        • Katz D.R.
        • Nunn J.D.
        • et al.
        Dendritic cells from human tissues express receptors for the immunoregulatory vitamin D3 metabolite, dihydroxycholecalciferol.
        Immunology. 1987; 61: 457
        • Dam T.N.
        • Moller B.
        • Hindkjaer J.
        • et al.
        The vitamin D3 analog calcipotriol suppresses the number and antigen-presenting function of Langerhans cells in normal human skin.
        J Investig Dermatol Symp Proc. 1996; 1: 72
        • Penna G.
        • Adorini L.
        1 Alpha,25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation.
        J Immunol. 2000; 164: 2405
        • Griffin M.D.
        • Lutz W.H.
        • Phan V.A.
        • et al.
        Potent inhibition of dendritic cell differentiation and maturation by vitamin D analogs.
        Biochem Biophys Res Commun. 2000; 270: 701
        • Gregori S.
        • Casorati M.
        • Amuchastegui S.
        • et al.
        Regulatory T cells induced by 1 alpha,25-dihydroxyvitamin D3 and mycophenolate mofetil treatment mediate transplantation tolerance.
        J Immunol. 1945; 167: 2001
        • O'Garra A.
        • Barrat F.J.
        In vitro generation of IL-10-producing regulatory CD4+ T cells is induced by immunosuppressive drugs and inhibited by Th1- and Th2-inducing cytokines.
        Immunol Lett. 2003; 85: 135
        • Fritsche J.
        • Mondal K.
        • Ehrnsperger A.
        • et al.
        Regulation of 25-hydroxyvitamin D3-1 alpha-hydroxylase and production of 1 alpha,25-dihydroxyvitamin D3 by human dendritic cells.
        Blood. 2003; 102: 3314
        • Hewison M.
        • Freeman L.
        • Hughes S.V.
        • et al.
        Differential regulation of vitamin D receptor and its ligand in human monocyte-derived dendritic cells.
        J Immunol. 2003; 170: 5382
        • Hewison M.
        • Zehnder D.
        • Chakraverty R.
        • et al.
        Vitamin D and barrier function: a novel role for extra-renal 1 alpha-hydroxylase.
        Mol Cell Endocrinol. 2004; 215: 31
        • Liu Y.J.
        IPC: professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors.
        Annu Rev Immunol. 2005; 23: 275
        • Steinman R.M.
        • Hawiger D.
        • Nussenzweig M.C.
        Tolerogenic dendritic cells.
        Annu Rev Immunol. 2003; 21: 685
        • Karmali R.
        • Hewison M.
        • Rayment N.
        • et al.
        1,25(OH)2D3 regulates c-myc mRNA levels in tonsillar T lymphocytes.
        Immunology. 1991; 74: 589
        • Nunn J.D.
        • Katz D.R.
        • Barker S.
        • et al.
        Regulation of human tonsillar T-cell proliferation by the active metabolite of vitamin D3.
        Immunology. 1986; 59: 479
        • Provvedini D.M.
        • Manolagas S.C.
        1 alpha,25-dihydroxyvitamin D3 receptor distribution and effects in subpopulations of normal human T lymphocytes.
        J Clin Endocrinol Metab. 1989; 68: 774
        • Lemire J.M.
        • Archer D.C.
        • Beck L.
        • et al.
        Immunosuppressive actions of 1,25-dihydroxyvitamin D3: preferential inhibition of Th1 functions.
        J Nutr. 1995; 125: 1704S
        • Boonstra A.
        • Barrat F.J.
        • Crain C.
        • et al.
        1alpha,25-Dihydroxyvitamin d3 has a direct effect on naive CD4(+) T cells to enhance the development of Th2 cells.
        J Immunol. 2001; 167: 4974
        • Overbergh L.
        • Decallonne B.
        • Waer M.
        • et al.
        1alpha,25-dihydroxyvitamin D3 induces an autoantigen-specific T-helper 1/T-helper 2 immune shift in NOD mice immunized with GAD65 (p524-543).
        Diabetes. 2000; 49: 1301
        • O'Kelly J.
        • Hisatake J.
        • Hisatake Y.
        • et al.
        Normal myelopoiesis but abnormal T lymphocyte responses in vitamin D receptor knockout mice.
        J Clin Invest. 2002; 109: 1091
        • Harrington L.E.
        • Mangan P.R.
        • Weaver C.T.
        Expanding the effector CD4 T-cell repertoire: the Th17 lineage.
        Curr Opin Immunol. 2006; 18: 349
        • Weaver C.T.
        • Hatton R.D.
        • Mangan P.R.
        • et al.
        IL-17 family cytokines and the expanding diversity of effector T cell lineages.
        Annu Rev Immunol. 2007; 25: 821
        • Bettelli E.
        • Korn T.
        • Kuchroo V.K.
        Th17: the third member of the effector T cell trilogy.
        Curr Opin Immunol. 2007; 19: 652
        • Korn T.
        • Oukka M.
        • Kuchroo V.
        • et al.
        Th17 cells: effector T cells with inflammatory properties.
        Semin Immunol. 2007; 19: 362
        • Daniel C.
        • Sartory N.A.
        • Zahn N.
        • et al.
        Immune modulatory treatment of TNBS colitis with calcitriol is associated with a change of a Th1/Th17 to a Th2 and regulatory T cell profile.
        J Pharmacol Exp Ther. 2007; 323: 23-33
        • Liu N.
        • Nguyen L.
        • Chun R.F.
        • et al.
        Altered endocrine and autocrine metabolism of vitamin D in a mouse model of gastrointestinal inflammation.
        Endocrinology. 2008; 149: 4799
        • Barrat F.J.
        • Cua D.J.
        • Boonstra A.
        • et al.
        In vitro generation of interleukin 10-producing regulatory CD4(+) T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines.
        J Exp Med. 2002; 195: 603
        • Gorman S.
        • Kuritzky L.A.
        • Judge M.A.
        • et al.
        Topically applied 1,25-dihydroxyvitamin D3 enhances the suppressive activity of CD4+CD25+ cells in the draining lymph nodes.
        J Immunol. 2007; 179: 6273
        • Gregori S.
        • Giarratana N.
        • Smiroldo S.
        • et al.
        A 1alpha,25-dihydroxyvitamin D(3) analog enhances regulatory T-cells and arrests autoimmune diabetes in NOD mice.
        Diabetes. 2002; 51: 1367
        • Mathieu C.
        • Badenhoop K.
        Vitamin D and type 1 diabetes mellitus: state of the art.
        Trends Endocrinol Metab. 2005; 16: 261
        • Spach K.M.
        • Nashold F.E.
        • Dittel B.N.
        • et al.
        IL-10 signaling is essential for 1,25-dihydroxyvitamin D3-mediated inhibition of experimental autoimmune encephalomyelitis.
        J Immunol. 2006; 177: 6030
        • Adorini L.
        • Penna G.
        • Giarratana N.
        • et al.
        Dendritic cells as key targets for immunomodulation by vitamin D receptor ligands.
        J Steroid Biochem Mol Biol. 2004; 89-90: 437
        • Dong X.
        • Bachman L.A.
        • Kumar R.
        • et al.
        Generation of antigen-specific, interleukin-10-producing T-cells using dendritic cell stimulation and steroid hormone conditioning.
        Transpl Immunol. 2003; 11: 323
        • Urry Z.
        • Xystrakis E.
        • Richards D.F.
        • et al.
        Ligation of TLR9 induced on human IL-10-secreting Tregs by 1alpha,25-dihydroxyvitamin D3 abrogates regulatory function.
        J Clin Invest. 2009; 119: 387
        • Vanham G.
        • Ceuppens J.L.
        • Bouillon R.
        T lymphocytes and their CD4 subset are direct targets for the inhibitory effect of calcitriol.
        Cell Immunol. 1989; 124: 320
        • Veldman C.M.
        • Cantorna M.T.
        • DeLuca H.F.
        Expression of 1,25-dihydroxyvitamin D(3) receptor in the immune system.
        Arch Biochem Biophys. 2000; 374: 334
        • Willheim M.
        • Thien R.
        • Schrattbauer K.
        • et al.
        Regulatory effects of 1alpha,25-dihydroxyvitamin D3 on the cytokine production of human peripheral blood lymphocytes.
        J Clin Endocrinol Metab. 1999; 84: 3739
        • Iho S.
        • Iwamoto K.
        • Kura F.
        • et al.
        Mechanism in 1,25(OH)2D3-induced suppression of helper/suppressor function of CD4/CD8 cells to immunoglobulin production in B cells.
        Cell Immunol. 1990; 127: 12
        • Meehan T.F.
        • DeLuca H.F.
        CD8(+) T cells are not necessary for 1 alpha,25-dihydroxyvitamin D(3) to suppress experimental autoimmune encephalomyelitis in mice.
        Proc Natl Acad Sci U S A. 2002; 99: 5557
        • Topilski I.
        • Flaishon L.
        • Naveh Y.
        • et al.
        The anti-inflammatory effects of 1,25-dihydroxyvitamin D3 on Th2 cells in vivo are due in part to the control of integrin-mediated T lymphocyte homing.
        Eur J Immunol. 2004; 34: 1068
        • Sigmundsdottir H.
        • Pan J.
        • Debes G.F.
        • et al.
        DCs metabolize sunlight-induced vitamin D3 to ‘program’ T cell attraction to the epidermal chemokine CCL27.
        Nat Immunol. 2007; 8: 285
        • Yu S.
        • Bruce D.
        • Froicu M.
        • et al.
        Failure of T cell homing, reduced CD4/CD8alphaalpha intraepithelial lymphocytes, and inflammation in the gut of vitamin D receptor KO mice.
        Proc Natl Acad Sci U S A. 2008; 105: 20834
        • Provvedini D.M.
        • Tsoukas C.D.
        • Deftos L.J.
        • et al.
        1 alpha,25-Dihydroxyvitamin D3-binding macromolecules in human B lymphocytes: effects on immunoglobulin production.
        J Immunol. 1986; 136: 2734
        • Shiozawa K.
        • Shiozawa S.
        • Shimizu S.
        • et al.
        1 alpha,25-dihydroxyvitamin D3 inhibits pokeweed mitogen-stimulated human B-cell activation: an analysis using serum-free culture conditions.
        Immunology. 1985; 56: 161
        • Lemire J.M.
        • Adams J.S.
        • Sakai R.
        • et al.
        1 alpha,25-dihydroxyvitamin D3 suppresses proliferation and immunoglobulin production by normal human peripheral blood mononuclear cells.
        J Clin Invest. 1984; 74: 657
        • Chen S.
        • Sims G.P.
        • Chen X.X.
        • et al.
        Modulatory effects of 1,25-dihydroxyvitamin d3 on human B cell differentiation.
        J Immunol. 2007; 179: 1634
        • Chapuy M.C.
        • Preziosi P.
        • Maamer M.
        • et al.
        Prevalence of vitamin D insufficiency in an adult normal population.
        Osteoporos Int. 1997; 7: 439
        • Holick M.F.
        Vitamin D deficiency.
        N Engl J Med. 2007; 357: 266
        • Ginde A.A.
        • Liu M.C.
        • Camargo Jr., C.A.
        Demographic differences and trends of vitamin D insufficiency in the US population, 1988–2004.
        Arch Intern Med. 2009; 169: 626
        • Martineau A.R.
        • Honecker F.U.
        • Wilkinson R.J.
        • et al.
        Vitamin D in the treatment of pulmonary tuberculosis.
        J Steroid Biochem Mol Biol. 2007; 103: 793
        • Martineau A.R.
        • Wilkinson R.J.
        • Wilkinson K.A.
        • et al.
        A single dose of vitamin D enhances immunity to mycobacteria.
        Am J Respir Crit Care Med. 2007; 176: 208
        • Nursyam E.W.
        • Amin Z.
        • Rumende C.M.
        The effect of vitamin D as supplementary treatment in patients with moderately advanced pulmonary tuberculous lesion.
        Acta Med Indones. 2006; 38: 3
        • Wejse C.
        • Gomes V.F.
        • Rabna P.
        • et al.
        Vitamin D as supplementary treatment for tuberculosis: a double-blind, randomized, placebo-controlled trial.
        Am J Respir Crit Care Med. 2009; 179: 843
        • Raghuwanshi A.
        • Joshi S.S.
        • Christakos S.
        Vitamin D and multiple sclerosis.
        J Cell Biochem. 2008; 105: 338
        • Spach K.M.
        • Hayes C.E.
        Vitamin D3 confers protection from autoimmune encephalomyelitis only in female mice.
        J Immunol. 2005; 175: 4119
        • Pedersen L.B.
        • Nashold F.E.
        • Spach K.M.
        • et al.
        1,25-Dihydroxyvitamin D3 reverses experimental autoimmune encephalomyelitis by inhibiting chemokine synthesis and monocyte trafficking.
        J Neurosci Res. 2007; 85: 2480
        • Spach K.M.
        • Pedersen L.B.
        • Nashold F.E.
        • et al.
        Gene expression analysis suggests that 1,25-dihydroxyvitamin D3 reverses experimental autoimmune encephalomyelitis by stimulating inflammatory cell apoptosis.
        Physiol Genomics. 2004; 18: 141
        • Mathieu C.
        • Gysemans C.
        • Giulietti A.
        • et al.
        Vitamin D and diabetes.
        Diabetologia. 2005; 48: 1247
        • Littorin B.
        • Blom P.
        • Scholin A.
        • et al.
        Lower levels of plasma 25-hydroxyvitamin D among young adults at diagnosis of autoimmune type 1 diabetes compared with control subjects: results from the nationwide Diabetes Incidence Study in Sweden (DISS).
        Diabetologia. 2006; 49: 2847
        • Harris S.S.
        Vitamin D in type 1 diabetes prevention.
        J Nutr. 2005; 135: 323
        • Ramos-Lopez E.
        • Jansen T.
        • Ivaskevicius V.
        • et al.
        Protection from type 1 diabetes by vitamin D receptor haplotypes.
        Ann N Y Acad Sci. 2006; 1079: 327
        • Bailey R.
        • Cooper J.D.
        • Zeitels L.
        • et al.
        Association of the vitamin D metabolism gene CYP27B1 with type 1 diabetes.
        Diabetes. 2007; 56: 2616
        • Giulietti A.
        • Gysemans C.
        • Stoffels K.
        • et al.
        Vitamin D deficiency in early life accelerates type 1 diabetes in non-obese diabetic mice.
        Diabetologia. 2004; 47: 451
        • Pappa H.M.
        • Gordon C.M.
        • Saslowsky T.M.
        • et al.
        Vitamin D status in children and young adults with inflammatory bowel disease.
        Pediatrics. 1950; 118: 2006
        • Pappa H.M.
        • Grand R.J.
        • Gordon C.M.
        Report on the vitamin D status of adult and pediatric patients with inflammatory bowel disease and its significance for bone health and disease.
        Inflamm Bowel Dis. 2006; 12: 1162
        • Vagianos K.
        • Bector S.
        • McConnell J.
        • et al.
        Nutrition assessment of patients with inflammatory bowel disease.
        JPEN J Parenter Enteral Nutr. 2007; 31: 311
        • Froicu M.
        • Cantorna M.T.
        Vitamin D and the vitamin D receptor are critical for control of the innate immune response to colonic injury.
        BMC Immunol. 2007; 8: 5
        • Froicu M.
        • Weaver V.
        • Wynn T.A.
        • et al.
        A crucial role for the vitamin D receptor in experimental inflammatory bowel diseases.
        Mol Endocrinol. 2003; 17: 2386
        • Kong J.
        • Zhang Z.
        • Musch M.W.
        • et al.
        Novel role of the vitamin D receptor in maintaining the integrity of the intestinal mucosal barrier.
        Am J Physiol Gastrointest Liver Physiol. 2007; 294: G208-G216
        • Zehnder D.
        • Bland R.
        • Williams M.C.
        • et al.
        Extrarenal expression of 25-hydroxyvitamin d(3)-1 alpha-hydroxylase.
        J Clin Endocrinol Metab. 2001; 86: 888
        • Abreu M.T.
        • Kantorovich V.
        • Vasiliauskas E.A.
        • et al.
        Measurement of vitamin D levels in inflammatory bowel disease patients reveals a subset of Crohn's disease patients with elevated 1,25-dihydroxyvitamin D and low bone mineral density.
        Gut. 2004; 53: 1129
        • Packey C.D.
        • Sartor R.B.
        Commensal bacteria, traditional and opportunistic pathogens, dysbiosis and bacterial killing in inflammatory bowel diseases.
        Curr Opin Infect Dis. 2009; 22: 292